Related Experiment Video
Updated: May 31, 2026

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
Regulation of human hepatocellular carcinoma cells by Spred2 and correlative studies on its mechanism
Xiao-Ni Ma1, Xiao-Yun Liu, Yue-Feng Yang
1Lanzhou University of Technology, Lanzhou 730050, PR China.
Abstract:
Members of the Spred gene family are negative regulators of the Ras/Raf-1/ERK pathway, which has been associated with several features of the tumor malignancy. However, the effect of Spred genes on hepatocellular carcinoma (HCC) remains uninvestigated. In the present work, we analyzed the in vitro and in vivo effects of Spred2 expression on the hepatic carcinoma cell line, SMMC-7721. In addition to attenuated ERK activation, which inhibited the proliferation and migration of unstimulated and HGF-stimulated SMMC-7721 cells. Adenovirus-mediated Spred2 overexpression induced the activation of caspase-3 and apoptosis, as well as reduced the expression level of Mcl-1. Most importantly, the knockdown of Spred2 markedly enhanced tumor growth in vivo. In conclusion, these results suggest that Spred2 could qualify as a potential therapeutic target in HCC.
Insights
Spred2 acts as a tumor suppressor in hepatocellular carcinoma (HCC) by inhibiting cell proliferation and migration. Its overexpression induces apoptosis, while its knockdown promotes tumor growth, suggesting Spred2 as a potential HCC therapeutic target.
Area of Science:
- Molecular Biology
- Oncology
- Cell Biology
Background:
- The Spred gene family negatively regulates the Ras/Raf-1/ERK pathway, implicated in tumor malignancy.
- The role of Spred genes, particularly Spred2, in hepatocellular carcinoma (HCC) has not been previously investigated.
Purpose of the Study:
- To investigate the in vitro and in vivo effects of Spred2 expression on the SMMC-7721 hepatic carcinoma cell line.
- To determine the therapeutic potential of Spred2 in hepatocellular carcinoma.
Main Methods:
- Adenovirus-mediated Spred2 overexpression in SMMC-7721 cells.
- Analysis of ERK activation, cell proliferation, migration, apoptosis (caspase-3 activation), and Mcl-1 expression.
- In vivo tumor growth assessment following Spred2 knockdown.
Main Results:
- Spred2 overexpression attenuated ERK activation, inhibiting proliferation and migration in SMMC-7721 cells.
- Overexpression of Spred2 induced caspase-3 activation and apoptosis, and reduced Mcl-1 expression.
- Knockdown of Spred2 significantly enhanced tumor growth in vivo.
Conclusions:
- Spred2 functions as a tumor suppressor in hepatocellular carcinoma.
- Spred2 inhibits HCC cell proliferation, migration, and promotes apoptosis.
- Spred2 represents a promising therapeutic target for HCC treatment.
More Related Videos
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
08:18Generation and Single-Cell Transcriptomic Analysis of Hepatocellular Carcinoma Organoids following Drug Treatment
Published on: May 26, 2026
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cirrhosis II: Pathophysiology
Abnormal Proliferation